pharmaceuticals-and-healthcare

Global Oncology Drugs Market Insights, Forecast to 2025


Published On : Sep 2018

Category : Pharmaceutical

No. of Pages : 119 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Oncology Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oncology Drugs in these regions.
This research report categorizes the global Oncology Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Oncology Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Oncology Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Oncology Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Oncology Drugs include
Novartis A.G
Laboratrio Cristlia
Medley Genomics
F. Hoffmann-La Roche Ltd
Icon Plc.
Sanofi S.A.
Laboratoires Pierre Fabre
Eurofarma Laboratrios S.A.
Ach Laboratrios Farmacuticos S.A.
Laboratorios IMA

Market Size Split by Type
Oral Therapy
Injectable Therapy
Market Size Split by Application
Targeted Therapy
Chemotherapy
Hormonal Therapy
Biologic Therapy

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Oncology Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Oncology Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oncology Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oncology Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Oncology Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oncology Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oncology Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global oncology drugs market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global oncology drugs market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global oncology drugs market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global oncology drugs market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global oncology drugs market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global oncology drugs market insights forecast to 2025, including the definition, classification, and industry chain structure of Global oncology drugs market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global oncology drugs market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global oncology drugs market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global oncology drugs market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global oncology drugs market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global oncology drugs market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global oncology drugs market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Oncology Drugs
Figure Global Oncology Drugs Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Oncology Drugs Production Market Share by Types (Product Category) in 2017
Figure Oral Therapy Product Picture
Table Major Manufacturers of Oral Therapy
Figure Injectable Therapy Product Picture
Table Major Manufacturers of Injectable Therapy
Table Global Oncology Drugs Market Size Growth Rate by Application 2018-2025 (MT)
Figure Targeted Therapy
Figure Chemotherapy
Figure Hormonal Therapy
Figure Biologic Therapy
Figure Oncology Drugs Report Years Considered
Figure Global Oncology Drugs Market Size 2016-2025 (Million US$)
Figure Global Oncology Drugs Sales 2016-2025 (MT)
Table Global Oncology Drugs Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Oncology Drugs Sales by Regions 2016-2025 (MT)
Table Global Oncology Drugs Sales Market Share by Regions 2016-2025
Figure Global Oncology Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Oncology Drugs Sales Market Share by Regions
Table Global Oncology Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Oncology Drugs Revenue Market Share by Regions 2016-2025
Figure Global Oncology Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Oncology Drugs Revenue Market Share by Regions
Table Global Oncology Drugs Sales by Manufacturers (2016-2018) (MT)
Table Global Oncology Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Oncology Drugs Sales Share by Manufacturers in 2017
Table Oncology Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Oncology Drugs Revenue Share by Manufacturers (2016-2018)
Figure Oncology Drugs Value Share by Manufacturers in 2017
Table Global Oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Oncology Drugs Price (2016-2018) (USD/Kg)
Table Oncology Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Oncology Drugs Product Category
Table Date of International Manufacturers Enter into Oncology Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Oncology Drugs Sales by Type (2016-2025) (MT)
Table Global Oncology Drugs Sales Share by Type (2016-2025)
Figure Global Oncology Drugs Sales Market Share by Type (2016-2025)
Figure Global Oncology Drugs Sales Market Share by Type in 2017
Table Global Oncology Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Oncology Drugs Revenue Share by Type (2016-2025)
Figure Global Oncology Drugs Revenue Market Share by Type (2016-2025)
Figure Global Oncology Drugs Revenue Market Share by Type in 2017
Table Oncology Drugs Price by Type 2013-2018 (USD/Kg)
Table Global Oncology Drugs Sales by Application (2016-2025) (MT)
Table Global Oncology Drugs Sales Share by Application (2016-2025)
Figure Global Sales Oncology Drugs Market Share by Application (2016-2025)
Figure Global Sales Oncology Drugs Market Share by Application (2016-2025)
Figure North America Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure North America Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Oncology Drugs Sales by Countries (2016-2025) (MT)
Table North America Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Oncology Drugs Sales Market Share by Countries
Table North America Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Oncology Drugs Revenue Market Share by Countries
Figure United States Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure United States Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Canada Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Mexico Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Oncology Drugs Sales by Type (2016-2025) (MT)
Table North America Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Oncology Drugs Market Share by Type
Table North America Oncology Drugs Sales by Application (2016-2025) (MT)
Table North America Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Oncology Drugs Market Share by Application
Table North America Oncology Drugs Sales by Company (2016-2018) (MT)
Table North America Oncology Drugs Sales Market Share by Company (2016-2018)
Figure North America Oncology Drugs Sales Market Share by Company in 2017
Figure Europe Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure Europe Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Oncology Drugs Sales by Countries (2016-2025) (MT)
Table Europe Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Oncology Drugs Sales Market Share by Countries
Table Europe Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Oncology Drugs Revenue Market Share by Countries
Figure Germany Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Germany Oncology Drugs Revenue Growth Rate (2016-2025) (MT)
Figure France Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure France Oncology Drugs Revenue Growth Rate (2016-2025) (MT)
Figure UK Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure UK Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Italy Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Russia Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Oncology Drugs Sales by Type (2016-2025) (MT)
Table Europe Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Oncology Drugs Market Share by Type
Table Europe Oncology Drugs Sales by Application (2016-2025) (MT)
Table Europe Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Oncology Drugs Market Share by Application
Table Europe Oncology Drugs Sales by Company (2016-2018) (MT)
Table Europe Oncology Drugs Sales Market Share by Company (2016-2018)
Figure Europe Oncology Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Oncology Drugs Sales by Countries (2016-2025) (MT)
Table Asia Pacific Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Oncology Drugs Sales Market Share by Countries
Table Asia Pacific Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Oncology Drugs Revenue Market Share by Countries
Figure China Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure China Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Japan Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Korea Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure India Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Australia Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Philippines Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Thailand Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Singapore Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Oncology Drugs Sales by Type (2016-2025) (MT)
Table Asia Pacific Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Oncology Drugs Market Share by Type
Table Asia Pacific Oncology Drugs Sales by Application (2016-2025) (MT)
Table Asia Pacific Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Oncology Drugs Market Share by Application
Table Asia Pacific Oncology Drugs Sales by Company (2016-2018) (MT)
Table Asia Pacific Oncology Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Oncology Drugs Sales Market Share by Company in 2017
Figure Central & South America Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Oncology Drugs Sales by Countries (2016-2025) (MT)
Table Central & South America Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Oncology Drugs Sales Market Share by Countries
Table Central & South America Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Oncology Drugs Revenue Market Share by Countries
Figure Brazil Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Brazil Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Argentina Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Oncology Drugs Sales by Type (2016-2025) (MT)
Table Central & South America Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Oncology Drugs Market Share by Type
Table Central & South America Oncology Drugs Sales by Application (2016-2025) (MT)
Table Central & South America Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Oncology Drugs Market Share by Application
Table Central & South America Oncology Drugs Sales by Company (2016-2018) (MT)
Table Central & South America Oncology Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Oncology Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Oncology Drugs Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Oncology Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Oncology Drugs Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Oncology Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Oncology Drugs Sales Market Share by Countries
Table Middle East and Africa Oncology Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Oncology Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Oncology Drugs Revenue Market Share by Countries
Figure GCC Countries Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Turkey Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure Egypt Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Oncology Drugs Sales Growth Rate (2016-2025) (MT)
Figure South Africa Oncology Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Oncology Drugs Sales by Type (2016-2025) (MT)
Table Middle East and Africa Oncology Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Oncology Drugs Market Share by Type
Table Middle East and Africa Oncology Drugs Sales by Application (2016-2025) (MT)
Table Middle East and Africa Oncology Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Oncology Drugs Market Share by Application
Table Middle East and Africa Oncology Drugs Sales by Company (2016-2018) (MT)
Table Middle East and Africa Oncology Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Oncology Drugs Sales Market Share by Company in 2017
Table Novartis A.G Company Details
Table Novartis A.G Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Novartis A.G Recent Development
Table Laboratrio Cristlia Company Details
Table Laboratrio Cristlia Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Laboratrio Cristlia Recent Development
Table Medley Genomics Company Details
Table Medley Genomics Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Medley Genomics Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Ltd Recent Development
Table Icon Plc. Company Details
Table Icon Plc. Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Icon Plc. Recent Development
Table Sanofi S.A. Company Details
Table Sanofi S.A. Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Sanofi S.A. Recent Development
Table Laboratoires Pierre Fabre Company Details
Table Laboratoires Pierre Fabre Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Laboratoires Pierre Fabre Recent Development
Table Eurofarma Laboratrios S.A. Company Details
Table Eurofarma Laboratrios S.A. Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Eurofarma Laboratrios S.A. Recent Development
Table Ach Laboratrios Farmacuticos S.A. Company Details
Table Ach Laboratrios Farmacuticos S.A. Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Ach Laboratrios Farmacuticos S.A. Recent Development
Table Laboratorios IMA Company Details
Table Laboratorios IMA Oncology Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Laboratorios IMA Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Oncology Drugs Value Chain
Table Typical Suppliers of Key Oncology Drugs Raw Material
Table Oncology Drugs Customers List
Table Oncology Drugs Sales Channels
Table Oncology Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top